Updated Jul 16, 2026 · Last SEC filing 2026-07-06
TAKEDA PHARMACEUTICAL CO LTD (TAK) has filed 33 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-06. 13 Form 144 notices of proposed sale were filed for TAK stock. InsiderAlpha tracks every TAK SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001395064 |
|---|
| Form 4 filings (90d) | 33 |
|---|---|
| Form 144 notices (90d) | 13 |
| Latest Form 4 filing | 2026-07-06 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Bitetti Teresa Marie | President, OBU | A — Grant or award | 43.9K | $0.00 | — | SEC | |
| Iijima Masami | Director | A — Grant or award | 1.8K | $0.00 | — | SEC | |
| Ricci Gabriele | Chief Data & Tech. Officer | A — Grant or award | 37.6K | $0.00 | — | SEC | |
| Duprey Lauren Rusckowski | Chief Transformation Officer | A — Grant or award | 45.1K | $0.00 | — | SEC | |
| Kim Julie So-Young | President and CEO | A — Grant or award | 50.4K | $0.00 | — | SEC | |
| Kim Julie So-Young | President and CEO | A — Grant or award | 22.8K | $0.00 | — | SEC | |
| Pacheco Rhonda Janice | President, U.S. Business Unit | A — Grant or award | 50.2K | $0.00 | — | SEC | |
| Pignagnoli Agosti Marcello | Head, Strat. & Port. Dev. | A — Grant or award | 27.6K | $0.00 | — | SEC | |
| Shannon Elaine Mary | Pres., Global Supply & Quality | A — Grant or award | 30.1K | $0.00 | — | SEC | |
| Plump Andrew Stewart | President, R&D | A — Grant or award | 125.4K | $0.00 | — | SEC | |
| Ibrahim Ramy Riad Ahmed | President, PDT BU | A — Grant or award | 25.1K | $0.00 | — | SEC | |
| Greenway Nicola Deidre Petal | Chief Human Resources Officer | A — Grant or award | 22.6K | $0.00 | — | SEC | |
| Farajallah Awny Samaan Botros | Chief Medical Officer | A — Grant or award | 17.6K | $0.00 | — | SEC | |
| Furney Natalie Anne Marie | Global General Counsel | A — Grant or award | 43.9K | $0.00 | — | SEC | |
| BROUSSARD BRUCE D | Director | A — Grant or award | 3.8K | $0.00 | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for TAKEDA PHARMACEUTICAL CO LTD (TAK). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Furuta Milano | 7 | $81.96M |
| Kim Julie So-Young | 6 | — |
| Miyabashira Asuka | 5 | $5.04M |
| Reed Kimberly A. | 3 | $5.68M |
| Weber Christophe Pierre | 3 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in TAK insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live TAK dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.